|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Nektar Therapeutics
| | | Phone: | (415) 482-5300 | Fax: | (415) 339-5300 | Year Established: | 1990 | Ticker: | NKTR | Exchange: | NASDAQ | Main Contact: | Lisa Decker, VP, Business Development & Alliance Management | | Other Contacts: | John Nicholson, Senior VP & COO Maninder Hora, Ph.D., Senior VP & Pharmaceutical Development & Manufacturing Stephen K. Doberstein, Ph.D., Senior VP & CSO Jillian B. Thomsen, VP, Finance & Chief Accounting Officer Timothy A. Riley, Ph.D., Senior VP, Global Research Gil M. Labrucherie, Senior VP & CFO Ivan Gergel, M.D., Senior VP & CMO Howard W. Robin, President & CEO
| | Company Description | Nektar Therapeutics (formerly INHALE Therapeutics Systems) is a research-based biopharmaceutical company whose mission is to discover and develop innovative medicines to address the unmet medical needs of patients. Our R&D pipeline of new investigational medicines includes treatments for cancer, auto-immune disease and chronic pain. We leverage Nektar's proprietary and proven chemistry platform in the discovery and design of our new therapeutic candidates. | |
|
|
|
|
|